Selling your veterinary practice in Nebraska in 2026 clears 5-7x EBITDA at the single-DVM lifestyle tier, 7-9.5x at 2-3 DVM general practice scale, 9.5-11.5x at the $1M-$3M EBITDA 4-8 DVM PE platform sweet spot (clean books to 12x), and 11-13x at $3M+ multi-doctor specialty/referral scale. Active NE buyers include Mars Veterinary Health, NVA/Ethos, Mission Pet Health, VetCor, PetVet Care Centers, Heartland, plus MedVet and Galaxy Vets for doctor-controlled exits under CPVM structure.

Quick Answer
Nebraska veterinary practices and animal hospitals sell for 5-7x EBITDA at the single-DVM lifestyle tier (below the PE diligence floor), 7-9.5x EBITDA at 2-3 DVM general practice scale, 9.5-11.5x EBITDA at the $1M-$3M EBITDA 4-8 DVM PE platform sweet spot (clean books to 12x), and 11-13x EBITDA at $3M+ EBITDA multi-doctor / specialty / referral scale (16-18x for marquee specialty hospitals). Multi-site groups command 12-15x platform-of-platform pricing. PE buyers contributed roughly 80% of total 2024 vet deal capital, with cumulative PE investment of $51.6B (2017-2023) + $9.3B (Jan-Apr 2024 alone). Active acquirers include Mars Veterinary Health (VCA, Banfield, BluePearl, strategic permanent capital), NVA / Ethos (JAB Holding), Mission Pet Health (Shore Capital, ~750+ clinics post-Mission+SVP merger July 2025), VetCor (Oak Hill + Harvest + Cressey), PetVet Care Centers (KKR), Heartland (Gryphon majority recap 2024-25), AmeriVet (AEA + ADIA), VPP (Audax), Innovetive Petcare (Metalmark), UVC (Nordic Capital), Suveto (Levine Leichtman), Veritas (Percheron), Encore Vet (North Castle), Pieper (Chicago Pacific Founders), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus, urgent care), VetEvolve (Varsity Healthcare), Thrive (TSG Consumer), plus MedVet (95% DVM-owned + Leonard Green minority) and Galaxy Vets (ESOP) for doctor-controlled exits.
Christoph Totter · Managing Partner, CT Acquisitions
Lower middle market M&A across professional services, home services, commercial services, and IT · Updated June 2026
Nebraska sits at the quiet edge of the animal-health consolidation map, and that single fact shapes what your practice is worth and how you should sell it. Cumulative private-equity investment in US veterinary reached $51.6 billion across 2017 to 2023, with another $9.3 billion in the first four months of 2024 alone (American Economic Liberties Project), and PE buyers supplied roughly 80% of 2024 deal capital. Yet of the fifteen-plus national platforms chasing that capital, only one, Blue River PetCare, has a confirmed hospital footprint inside Nebraska, in Omaha and Lincoln. The rest acquire nationally but have not planted a flag here, so a Nebraska owner is usually running a quieter process than a seller in Texas or the Carolinas, and the job is to manufacture competition rather than assume it.
This guide is written for the Nebraska DVM who wants the price and the path in plain terms. It covers 2026 multiples by EBITDA tier, the wellness-plan premium that moves general-practice value most, the national buyer pool and the one platform already on Nebraska ground, and the parts of a Nebraska deal that genuinely differ from the national template. Three of those are load-bearing here: Nebraska restricts non-veterinarian ownership, but through an unusual back door; its employment non-compete law is among the strictest in the country and reshapes how buyers retain your doctors; and its only veterinary-education pipeline is a shared two-plus-two program with Iowa State, which keeps associate supply tight, especially west of Lincoln.
CT Acquisitions runs confidential, buy-side processes. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing. For wider context, see our veterinary hub guide, our Private Equity in Veterinary 2026 report, our national guide to selling a veterinary practice, our specialty hospital guide, and our 36-month veterinary practice exit playbook. The free valuation survey takes about three minutes.
Nebraska veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers apply nationally, but read against a shallow in-state bidder pool. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the threshold where corporate diligence pays for itself, so it usually changes hands between DVMs. The tiers climb from there.
Nebraska veterinary practices are priced off adjusted EBITDA and sorted into size tiers. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA typically clears 5x to 7x and changes hands between doctors or small regional groups rather than going to a platform, a common pattern across the Sandhills and the Panhandle. A two-to-three-DVM general practice at $500K to $1M of adjusted EBITDA lands in the 7x to 9.5x range, with the top of that band earned by high-margin books that do not lean on one doctor. The four-to-eight-DVM hospital at $1M to $3M is the tier a platform will travel for and clears 9.5x to 11.5x, reaching 12x when the books are clean and a second-tier doctor bench is in place. Above $3M, usually a multi-doctor specialty or referral group, pricing runs 11x to 13x and can stretch to 16x to 18x for a marquee specialty hospital an aggregator wants for geographic fill. Specialty, emergency and around-the-clock hospitals carry a 1.5x to 3x premium over general practice. The R.L. Hulett Q1 2025 Pet M&A Update reported closed transactions spanning 6x to 16x adjusted EBITDA, and per the American Economic Liberties Project private-equity buyers supplied roughly 80% of 2024 veterinary deal capital. A wellness-plan book above 15% of eligible general-practice cases routinely adds 0.5x to 1.5x on top of the size-tier baseline.
| Nebraska practice profile | Typical multiple | What moves it in Nebraska |
|---|---|---|
| Single-DVM lifestyle / rural mixed-animal under $500K EBITDA | 5-7x EBITDA | Below the platform floor; sells DVM-to-DVM, common across the Sandhills and Panhandle |
| 2-3 DVM general practice ($500K-$1M EBITDA) | 7-9.5x EBITDA | Draws the Omaha-Lincoln incumbent as a bolt-on, but usually one bidder unless you recruit more |
| 4-8 DVM hospital ($1M-$3M EBITDA) | 9.5-11.5x EBITDA (clean books to 12x) | The tier a national platform will fly in for; associate bench and wellness penetration decide the top end |
| $3M+ EBITDA multi-doctor / specialty / referral | 11-13x EBITDA (16-18x for marquee specialty) | Scarce in Nebraska, so a strong referral hospital in Omaha faces real out-of-state demand |
| Multi-site groups (3+ hospitals) | 12-15x EBITDA | A ready-made eastern-Nebraska cluster is rare and commands platform-of-platform pricing |
The lever that separates a floor multiple from a strong one is competition, and in Nebraska that competition has to be built. A four-doctor Omaha hospital with $1.5M of EBITDA taken quietly to the one platform already in town might settle at 9.5x to 10.5x, roughly $14M to $16M. Placed into a confidential process that pulls two or three national acquirers who do not yet operate in Nebraska but want the metro, that same hospital can draw a second and third bid, and a buyer who marks tuck-ins up on its own balance sheet will pay one to two turns more to win a foothold in a state where it has none.
For a Nebraska general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Recurring monthly membership revenue turns transactional cash flow into something a buyer can underwrite as predictable, and every acquirer that would look at an Omaha or Lincoln hospital now expects it.
For a Nebraska general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Practice-management software vendors put plan penetration above 18% of eligible patients across the US, and members spend two to three times what non-plan clients do, so a healthy book converts transactional cash flow into monthly recurring revenue that buyers value more highly because it smooths seasonality, signals retention, and supports a defensible lifetime-value calculation after close. Banfield built the model at scale with its Optimum Wellness Plans, and a national buyer sizing up a Nebraska hospital expects it to be on a branded plan within a year to eighteen months. The way to capture the premium is to stand the plan up 18 to 24 months before going to market, push penetration past 12 to 15% of eligible general-practice cases, break the recurring revenue out as its own line in the financial pack, and carry it into the quality-of-earnings report as a distinct book. Nebraska hospitals that arrive at market above 20% penetration with average member tenure past two years regularly clear 75 to 150 basis points above their size-tier baseline. The mirror image is the risk: a purely transactional practice with thin repeat visits, which describes many of the older mixed-animal books in rural Nebraska, gets marked down in the same diligence.
In Nebraska deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention, not patient demand, and that constraint bites harder here because the state replaces departing doctors slowly. The structure leans on the seller and the associate bench staying put.
In Nebraska deals the binding constraint a buyer underwrites is doctor retention rather than patient demand, and it bites harder here because the state graduates only a small resident DVM cohort each year. A typical Nebraska two-to-eight-DVM hospital sold to a platform closes on roughly 70 to 80% cash, with 10 to 20% rolled into equity in a Newco or a platform-level holding company and 5 to 15% held as an earnout keyed to the selling doctor clinical hours through years one to three, associate retention through years one to two, and trailing-twelve EBITDA holding its baseline. Above $5M of enterprise value the rollover slice usually rises to 20 to 30%. The recurring fight is production-comp normalization: many Nebraska owners run associate pay at 20 to 25% of production plus distributions, while platforms reset associates to 22 to 24% straight production with no profit share and then recompute adjusted EBITDA on that basis, so agreeing a ProSal floor with the buyer six to twelve months before signing heads off the haircut. The clawbacks have teeth: a typical structure fires if the selling DVM drops under 32 hours a week or under 80% of historical production for any 60-day window in the earnout period, and an associate departure inside 18 months releases part of the escrow back to the buyer. Because Nebraska voids overbroad employment non-competes outright, buyers in this state cannot lean on a covenant to hold an associate, so they weight the retention earnout and sign-on economics even more heavily than they would in a blue-pencil state. Relief-doctor hours through services such as IndeVets or Roo generally do not count toward the production thresholds, and relief coverage is harder to source in Nebraska than in a coastal metro, which is one more reason buyers prize a stable salaried bench.
The gap between what a platform pays for a single Nebraska hospital and what that hospital is worth once it sits inside a larger group is the real prize for a seller here. Because only one platform is already in state, the spread shows up most when an out-of-state buyer wants a Nebraska beachhead.
The gap between what a platform pays for a single Nebraska hospital and what that hospital is worth once it sits inside a larger group is where a seller premium actually lives. A standalone four-doctor Omaha general practice at $1.5M of EBITDA sold direct might clear 9.5x to 10.5x. Tucked into a group that itself trades at a 15x to 18x platform multiple, the same earnings get re-marked at five to seven turns higher on the acquirer books, which is why a buyer that wants an entry point into Nebraska will pay 11x to 12x for a $1M to $2M hospital in the right metro. The catch is that the premium only appears when the buyer actually wants your geography or species mix. An off-thesis hospital, wrong corner of a rural state, wrong case load, or soft earnings quality, gets the floor multiple no matter how many platforms exist nationally. Nebraska makes this sharper than a dense state: with Blue River PetCare the only confirmed in-state operator, the owner who simply waits for inbound interest is negotiating against one bidder, while the owner who runs a confidential process to four to six national acquirers is far more likely to reach the one for whom a Nebraska entry is on-thesis, and to convert that into one or two extra turns. Tighter acquisition-debt markets through 2024 and 2025 trimmed platform multiples by a turn or two from the 2021 to 2022 peak, and the late-2025 rate cuts have restarted committed financing, which is part of why national buyers are willing to travel again in 2026.
The Nebraska buyer pool is the national buyer pool, with one difference that matters: only Blue River PetCare has confirmed hospitals on the ground here, in Omaha and Lincoln. The rest acquire across all 50 states but would be entering Nebraska fresh, which gives a well-run seller real negotiating room.
The Nebraska buyer pool is the national buyer pool, but with only one member confirmed on the ground. Blue River PetCare, a general-practice consolidator, runs the hospitals confirmed in Omaha and Lincoln per the CT Acquisitions Nebraska buyer ledger, which makes it the incumbent bolt-on buyer for an eastern-corridor seller. Every other platform below acquires nationally and could enter Nebraska for the right hospital. Mars Veterinary Health is the largest, folding VCA, Banfield and the BluePearl specialty and emergency network under one strategic, permanent-capital umbrella rather than a fund. NVA sits under JAB Holding Company with its Ethos specialty and emergency division, and the 2022 FTC consent order from the SAGE deal still restricts JAB specialty and ER acquisitions within 25 miles of an existing JAB clinic in California and Texas. Mission Pet Health, backed by Shore Capital Partners, reached roughly 750 clinics after the July 2025 merger of Mission Veterinary Partners and Southern Veterinary Partners. VetCor is led by Oak Hill Capital with Harvest Partners and Cressey & Co. PetVet Care Centers has been owned by KKR since 2022 (not Onex). Heartland Veterinary Partners is now Gryphon Investors majority after its 2024 to 2025 recap (not American Securities); AmeriVet is held by AEA Investors and the Abu Dhabi Investment Authority since the February 2022 recap (not Imperial Capital). Other national platforms in the pool include Veterinary Practice Partners (Audax), Innovetive Petcare (Metalmark), United Veterinary Care (Nordic Capital, not Atlantic Street), Suveto (Levine Leichtman, not LongueVue), Veritas (Percheron), Encore Vet Group (North Castle), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus urgent care), VetEvolve (Varsity Healthcare) and Thrive Pet Healthcare (TSG Consumer). The doctor-controlled route is real for Nebraska owners too: MedVet is roughly 95% DVM and employee owned with a Leonard Green minority and Oak Hill Advisors debt, and Galaxy Vets is the first US consolidator built as an employee stock ownership plan, both options for a seller who wants liquidity without handing clinical control to a fund.
Buyers rank Nebraska veterinary sub-verticals on the same hierarchy they use everywhere, but the state tilts the mix toward food-animal and mixed practice, which sit outside the companion-pet roll-up thesis. General practice in the metros is the backbone; specialty and referral sit at the top of the range but are scarce here.
Buyers rank Nebraska veterinary sub-verticals on a clear hierarchy, and the state mix pushes a larger share of practices out of the platform lane than a coastal state would. Companion-animal general practice is the backbone of the thesis at 5x to 12x adjusted EBITDA by size, with buyers favoring two-to-eight-DVM hospitals in Omaha, Lincoln and their suburbs that carry a stable associate bench, own or control their real estate, and run a wellness book. Specialty and referral practices, covering surgery, internal medicine, oncology, cardiology, neurology, dermatology and ophthalmology, trade highest at 11x to 14x and up to 16x to 18x for a marquee multi-specialist hospital, but they are thin on the ground in Nebraska, so a strong referral hospital in Omaha faces genuine out-of-state demand rather than a crowded local field. Emergency, urgent-care and around-the-clock hospitals carry 11x to 13x on the scarcity of overnight staffing, a scarcity that is more acute in Nebraska given the small resident DVM pipeline. Mixed-animal, equine and food-animal practices, which make up a large share of the state west of Lincoln, are a separate buyer pool at 5x to 8x, since production-animal economics, travel logistics and USDA APHIS oversight do not standardize well at platform level and the buyers tend to be other large-animal DVMs or regional groups. Much of rural Nebraska is a USDA-designated food-animal veterinary shortage area, which depresses platform appetite further. Mobile and house-call practices are capital-light but doctor-time-bound with little platform appetite because there is no real-estate moat. A multi-site companion-animal group of three or more hospitals is the single most attractive Nebraska archetype precisely because it is rare, giving a buyer an instant eastern-Nebraska cluster worth platform-of-platform multiples of 12x to 15x.
Our national data on veterinary practice valuation multiples shows what buyers actually pay by tier.
What is your Nebraska veterinary practice actually worth?
CT Acquisitions runs a confidential, buy-side process across the 15+ active PE-backed veterinary consolidators plus MedVet and Galaxy Vets for DVMs who want a doctor-controlled exit. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing.
Nebraska is a one-platform companion-animal market anchored on the Omaha-Lincoln corridor, with a large food-animal hinterland that sits outside the roll-up thesis. The state restricts non-vet ownership through its corporation law, and its only DVM pipeline is a shared program with Iowa State.
Nebraska is a one-platform companion-animal market. Blue River PetCare is the only national consolidator with confirmed hospitals in the state, in Omaha and Lincoln, which sit about an hour apart on I-80 and function as a single eastern buyer corridor. Omaha, a metro of roughly one million, carries an affluence that punches above its size, home to Berkshire Hathaway, Mutual of Omaha and Kiewit, with metro median household income near $84,500 (US Census Bureau), which supports stronger premium-companion spend than a metro that size usually shows; Lincoln adds government and university stability. West of Lincoln the map thins quickly into small-metro and rural country, Grand Island and Kearney two and a half to three hours out, the Panhandle six, where food-animal and mixed practice dominate and no platform has a hub. On ownership, Nebraska restricts non-veterinarian control, but the restriction does not sit in the veterinary act. The Nebraska Veterinary Medicine and Surgery Practice Act (Neb. Rev. Stat. 38-3301 et seq.) governs licensure and scope and is silent on who may own a practice; the constraint comes from the Nebraska Professional Corporation Act (Neb. Rev. Stat. 21-2216), which requires the shareholders, directors and officers of a professional corporation to be licensed in the profession the corporation renders. On the labor side, Nebraska has no stand-alone veterinary college. Its only pipeline is the University of Nebraska-Lincoln and Iowa State two-plus-two Professional Program in Veterinary Medicine, where a resident cohort of roughly 25 to 30 students completes the first two years in Lincoln and the clinical years in Ames, and that cohort skews food-animal, so metro companion-animal hiring stays competitive and rural coverage stays scarce.
A one-platform state: Omaha and Lincoln share a single confirmed institutional buyer, and the vast rural west is functionally off the platform map.
Proximity to an existing platform is the hook, but it only converts if you clear the size bar, and three more factors, metro depth, DVM labor supply, and the demand trend, decide how hard buyers actually compete. Here is how Nebraska reads on all five.
| Factor | What it means for your exit |
|---|---|
| Buyers near you | Only one national platform (Blue River PetCare) has a confirmed Nebraska footprint, in Omaha and Lincoln, which sit ~1 hour apart and form the state’s single eastern buyer corridor; Omaha’s 2-hour reach mostly crosses into Council Bluffs (same metro) and runs out into farmland, and the central/western two-thirds of the state has no confirmed platform presence. |
| Your size gate | Inside the Omaha-Lincoln corridor the bar to attract the incumbent as a bolt-on is relatively low, so even a solid solo or multi-DVM companion practice gets a real conversation, but with essentially one confirmed bidder that is a conversation, not an auction; in rural/western Nebraska the bar runs off the end of the platform map and most practices trade to local/regional buyers. |
| Metro depth | Omaha (~1.0M) is a mid-to-large anchor and Lincoln (~0.35M) a stable small-mid metro, but even together the bench is thin (one confirmed platform), so bidder DEPTH is the constraint, not raw population; the rest of the state is small-metro-to-rural. |
| DVM labor supply | Nebraska has no stand-alone vet school; its only pipeline is the UNL/Iowa State PPVM 2+2, which graduates only ~26-30 resident DVMs a year and skews food-animal, and much of rural Nebraska is a USDA-designated food-animal veterinary shortage area, so staffability is a modest tailwind in the eastern corridor and a real headwind in the rural west. |
| Demand trend | Omaha punches above its size on affluence (Berkshire Hathaway, Mutual of Omaha, Kiewit; metro median HH income ~$84.5K) and Lincoln adds government/university stability, giving the eastern corridor a genuine premium-companion-spend tailwind, while depopulating, aging, food-animal rural counties are a headwind. |
If you own a companion-animal practice in Omaha or Lincoln, you sit inside the one part of Nebraska where an institutional buyer is already operating: Blue River PetCare has confirmed hospitals in both cities, which are only about an hour apart on I-80, so they function as a single eastern buyer corridor a platform can service from one hub. That is real proximity, and Omaha adds a genuine sweetener most metros its size don’t have, concentrated insurance and finance wealth (Berkshire Hathaway, Mutual of Omaha, Kiewit) that makes it a stronger, more resilient premium-pet market than a ~1.0M metro would suggest, with Lincoln’s government-and-university base adding stability. But proximity here is proximity to essentially ONE confirmed bidder, not a field of them, so this is a market where you get a serious conversation, not an automatic auction. Your bargaining position comes from being a clean, differentiated, multi-DVM practice the incumbent wants to keep in its cluster, and from proactively bringing outside national buyers to the table to create the tension the thin local bench won’t supply on its own.
Your scale gate slides with location. In the Omaha-Lincoln corridor the bar is relatively low because a nearby platform can absorb even a solid solo practice as a bolt-on, but ‘clears the bar’ means ‘gets a real bid,’ not ‘triggers a bidding war,’ because the bench is thin. Push west and the gate rises fast: central Nebraska (Grand Island, Kearney) is two-and-a-half to three hours out, the Panhandle is six, there is no confirmed platform hub to lean on, and much of that country is food-animal and mixed practice that sits outside the companion-pet consolidation thesis entirely. Those practices are succession and relationship sales to local or regional buyers, not roll-up targets. Labor reinforces the split and is the state’s real soft spot: Nebraska has no stand-alone vet school, only the UNL/Iowa State PPVM 2+2 program that sends a tiny ~26-30 resident cohort a year to Ames for its clinical training, and the USDA classifies much of rural Nebraska as a food-animal veterinary shortage area, so a buyer’s biggest question, can I staff this after the founder slows down, is answered ‘modestly yes’ in the east and ‘that’s the whole problem’ in the west.
Nebraska’s non-compete law then quietly reshapes structure in the seller’s favor on the part that matters most. Nebraska is one of the strictest states in the country on EMPLOYMENT non-competes: its courts refuse to blue-pencil an overbroad covenant and void it entirely rather than narrow it, so a buyer’s restrictive covenants on your associate DVMs are unusually fragile and cannot be rescued by a judge. That pushes buyers to retain your doctors, whose production is the value they’re buying, through long employment agreements, retention bonuses, equity, and earn-outs instead of covenants. At the same time, a covenant ANCILLARY TO THE SALE of your business is judged under a friendlier reasonableness standard and is enforceable, so as the selling owner you can and will be bound to a normal sale non-compete protecting the goodwill you’re selling. On tax, your state rate on the gain is falling year to year (5.20% in 2025, 4.55% in 2026, a flat 3.99% top scheduled for 2027), and Nebraska’s narrow once-in-a-lifetime special capital-gains/extraordinary-dividend exclusion can sharply cut state tax on a QUALIFYING stock sale of employer corporate stock, though many vet deals run as asset sales or through friendly-PC/MSO structures that don’t qualify, so treat it as a plan-ahead item with a Nebraska tax advisor. Net: eastern-corridor Nebraska is a real but single-bidder institutional market with a genuine affluence tailwind and a favorable-to-sellers non-compete regime, best worked by manufacturing competition rather than assuming it; rural and western Nebraska is a labor-constrained, food-animal-weighted succession market where the scarce commodity is the next veterinarian, not the buyer’s check.
Selling a Nebraska veterinary practice touches three regulatory layers, and the first is the one that genuinely shapes the deal: Nebraska restricts non-veterinarian ownership, but through its corporation law rather than its veterinary act, so a corporate buyer needs a friendly-DVM PC plus a management services organization. The layers are CPVM structuring, state and federal permit transfers, and the antitrust backdrop.
Selling a Nebraska veterinary practice touches three regulatory layers, and the first is the subtle one. Nebraska restricts corporate ownership of a veterinary practice, but the restriction is not written into the veterinary code the way a reader expects. The Nebraska Veterinary Medicine and Surgery Practice Act (Neb. Rev. Stat. 38-3301 et seq.) regulates who may be licensed and what the practice of veterinary medicine covers, and it is silent on practice ownership. The ownership limit instead flows from the Nebraska Professional Corporation Act: Neb. Rev. Stat. 21-2216 requires that all shareholders, directors and officers of a professional corporation, except a secretary or assistant secretary, be licensed to render the same professional service the corporation renders. Because a veterinary practice organized as a professional corporation must therefore be owned by a licensed veterinarian, a private-equity or corporate buyer cannot hold the practice entity outright. The solution is the friendly-DVM PC plus management services organization structure: a licensed Nebraska veterinarian owns the professional corporation that holds the license and employs the doctors, while the buyer owns a separate MSO that holds the non-clinical assets and provides administration under a management services agreement, with a stock-transfer-restriction agreement keeping the PC friendly. The management side must not control clinical judgment. Because the restriction is statutory and real, a Nebraska deal carries the extra friendly-PC-plus-MSO structuring cost, commonly $50K to $150K in legal work, that a permissive state like Oregon or Georgia avoids. The second layer is permits and is partly federal. The practice keeps its veterinary establishment registration current with the Nebraska Board of Veterinary Medicine and Surgery under the Department of Health and Human Services, and the board should be notified of the ownership change; separately, each location that stores or dispenses controlled substances needs its own DEA registration, the new owner obtains a fresh DEA number, the controlled-substance inventory transfers with a documented count signed by both sides at close, and Schedule II drugs move on DEA Form 222. The third layer is antitrust posture. The 2020 NVA / Compassion-First and 2022 JAB / SAGE FTC consent orders remain in force, the May 2024 FTC and DOJ request for information named veterinary roll-ups as a concern, and a January 2025 FTC settlement signaled that stealth sub-HSR acquisitions in fragmented healthcare verticals are on the agenda. In a one-platform state like Nebraska the near-term antitrust risk is lower than in a saturated metro, but a buyer that already holds nearby capacity can still draw a longer look.
For a Nebraska seller the sequence is specific. First, ownership: because the Professional Corporation Act bars a non-veterinarian from holding the practice entity, plan on a friendly-DVM PC plus MSO from the start, identify the licensed Nebraska veterinarian who will hold the PC, and build the management services agreement and stock-transfer restrictions so the buyer controls the economics without controlling clinical care. Second, permits: keep the veterinary establishment registration with the Nebraska Board of Veterinary Medicine and Surgery current and notify the board of the ownership change. Third, DEA: the new owner secures a fresh registration, the controlled-substance inventory transfers with a signed count, and Schedule II items move on Form 222. Fourth, antitrust: if a bidder already operates near Omaha or Lincoln, build extra review time into the calendar, though in a state with one incumbent that risk is usually modest. Plan on roughly 90 to 150 days from signing to close, with the friendly-PC formation and DEA reissuance as the steps that most often set the pace.
The deal mechanics on a Nebraska veterinary sale follow the national pattern with two Nebraska-specific bends: the ownership transfer runs through a friendly-DVM PC plus MSO because of the Professional Corporation Act, and non-compete enforceability splits sharply, with employment covenants among the weakest in the country and sale covenants holding.
The deal mechanics on a Nebraska veterinary sale follow the national pattern with two Nebraska bends. Rollover equity typically runs 20 to 30% of proceeds into a Newco or platform holding company on deals above $5M of enterprise value, vesting over three to five years and monetizing at the next recap on a four-to-six-year hold. The DVM-retention earnout holds 5 to 15% of consideration against the seller continued clinical hours, associate retention through years one to two, and EBITDA stability, with a clawback if the seller falls under 32 hours a week or under 80% of pre-close production for any 60-day window. Production-comp normalization is the same recut buyers apply everywhere: associates reset to 22 to 24% straight production and adjusted EBITDA is recomputed on that basis, which can trim it 5 to 15% unless the seller pre-empts it. The first Nebraska-specific point is the ownership transfer itself. Because Neb. Rev. Stat. 21-2216 requires a professional corporation to be owned by licensed veterinarians, the parties do not transfer the practice entity to the buyer; they stand up a friendly-DVM PC and an MSO, and the MSO acquires the non-clinical assets and signs a long-term management services agreement, a step that adds time and legal cost a permissive state avoids. The second is non-competes, where Nebraska is an outlier. Nebraska courts will not blue-pencil an overbroad employment non-compete; they void it entirely rather than narrow it, which makes a restrictive covenant on an associate DVM unusually fragile and pushes buyers to retain doctors through long employment agreements, retention bonuses, equity and earnouts instead. A covenant ancillary to the sale of the business, given by the selling owner, is judged on a friendlier reasonableness standard and is enforceable, so the seller can expect to be bound to a normal sale non-compete protecting the goodwill being sold. On tax, Nebraska treats the gain as ordinary income on a top rate that is falling year to year, 5.20% in 2025, 4.55% in 2026, with a flat 3.99% top scheduled for 2027 under LB 754 (Nebraska Department of Revenue), and the states narrow once-in-a-lifetime special capital-gains exclusion can sharply cut state tax on a qualifying sale of employer corporate stock, though many veterinary deals run as asset sales or through friendly-PC and MSO structures that do not qualify, so treat it as a plan-ahead item with a Nebraska tax advisor. Real estate is commonly split into a separate entity at signing and leased back on a 15-to-20-year triple-net lease, leaving the building as independent optionality at roughly 5.5% to 7.5% cap rates.
The engine behind the Nebraska selling wave is succession, not a doctor shortage in the aggregate, though Nebraska feels the staffing side more acutely than most because it trains so few resident DVMs. An aging pool of owner-operators is reaching the decision to step back.
The engine behind the Nebraska selling wave is succession. The 2025 AVMA Report on the Economic State of the Veterinary Profession counts roughly 130,415 DVMs in the US workforce, most in small-animal practice, and the AAVMC 2024 supply-and-demand study concluded that new graduates from existing colleges should meet aggregate demand through the mid-2030s, with real shortfalls concentrated in rural, food-animal and emergency staffing rather than across the board, exactly the segments that dominate Nebraska outside Omaha and Lincoln. The more durable driver is demographic. Peer-reviewed survey work published in JAVMA over 2024 and 2025 found that 61% of clinical-practice DVMs intend to cut clinical hours within five years and 31% intend to stop clinical work entirely, and roughly 8% of working veterinarians are already 66 or older. Nebraska feels this from two directions at once. Its metro practices draw on a small resident pipeline, the roughly 25 to 30 students a year in the UNL and Iowa State two-plus-two program, which keeps associate supply tighter than in states with their own large veterinary college, while its base of owner-operators who built practices in the 1980s and 1990s is now reaching retirement with few in-state successors behind them. With private-equity capital restarted by the late-2025 rate cuts and national buyers willing to travel for a Nebraska beachhead, 2026 through 2030 is the structural window when more Nebraska owners cross 60 than at any prior point.
A generalist advisor who treats a Nebraska veterinary practice as any other services business will miss the levers that move the price and will misread the Nebraska rules, most importantly the ownership restriction hidden in the corporation law and the unusually seller-favorable non-compete regime.
A generalist advisor who treats a Nebraska veterinary practice as any other services business will miss the levers that move the price and will misread the local rules. The wellness-plan documentation, the rollover-equity slice that monetizes at the next recap, the 5 to 15% production-comp recut buyers apply to pre-close numbers, the 32-hour and 80%-production earnout thresholds, and the split between enforceable sale-of-business non-competes and fragile associate covenants are all veterinary-specific diligence items. Two of them are distinctly Nebraskan. The first is that the ownership restriction lives in the Professional Corporation Act (Neb. Rev. Stat. 21-2216), not the veterinary act, so an advisor who reads only the veterinary code can wrongly conclude the state is permissive and skip the friendly-DVM PC plus MSO the deal actually needs. The second is that Nebraska voids overbroad employment non-competes outright, so doctor retention has to be engineered through pay and equity rather than paper, which changes how you value the associate bench and how a buyer prices key-person risk. A Nebraska seller working with someone who knows the current platform cap tables, that Blue River PetCare is the lone in-state incumbent, and how Nebraska actually licenses and enforces, negotiates as an equal rather than being educated by the buyer diligence team at their own expense.
Nebraska owners who reach the top of their tier prepare deliberately over 12 to 24 months. The priorities are the wellness book, a real associate bench, clean normalized earnings, the friendly-PC structuring plan, and manufacturing a competitive process in a state with one incumbent buyer.
Nebraska owners who reach the top of their tier almost always prepared deliberately. With 12 to 24 months of runway, work down this list:
For the broader framework, see our Private Equity in Veterinary 2026 report, our 36-month veterinary exit playbook, and the lower middle market buyer mandate report.
The mistakes that cost Nebraska sellers money cluster around anchoring on revenue, misreading the ownership rule, drafting non-competes that a Nebraska court will void, and waiting for the one in-state buyer instead of building an auction.
Companion guides: Sell Your Veterinary Practice / Animal Hospital (national overview) Private Equity in Veterinary 2026: Active Platforms, Multiples, and Consolidation How to Sell a Veterinary Practice 2026 Selling a Veterinary Specialty Hospital in 2026 How to Prepare Your Veterinary Practice for a Sale or Exit (2026) How to Buy a Veterinary Pract…
Companion guides:
Veterinary is one of the deepest consolidation pools in healthcare-adjacent services, but Nebraska is a quiet seat in it rather than a crowded one. Cumulative private-equity investment reached $51.6 billion over 2017 to 2023 with another $9.3 billion in early 2024 (American Economic Liberties Project), and fifteen-plus national platforms compete alongside Mars permanent capital, yet only Blue River PetCare has a confirmed Nebraska footprint, in Omaha and Lincoln. A structural seller wave is building as 61% of clinical-practice DVMs plan to cut clinical hours within five years (JAVMA 2024-2025), and Nebraska feels the staffing side of that wave acutely because its only pipeline is the small UNL and Iowa State two-plus-two program. A Nebraska hospital with four to eight doctors, wellness penetration past 12 to 15%, normalized production comp, a current veterinary establishment registration and DEA registration, clean real-estate optionality, a friendly-DVM PC plus MSO plan ready under Neb. Rev. Stat. 21-2216, and doctor retention built on pay rather than a fragile non-compete can realistically reach the upper end of its 9.5x to 11.5x tier, with multi-site groups reaching 12x to 15x. The things that most often cost Nebraska sellers money are an unprepared production-comp recut, outreach to stale buyer lists, misreading the ownership rule as permissive when the Professional Corporation Act restricts it, drafting associate non-competes a Nebraska court will void, and accepting the lone in-state buyer first offer instead of running a confidential process across the national pool.
This guide reflects 2026 veterinary M&A conditions and CT Acquisitions direct work with active acquirers. Multiples are directional, not a guarantee; every practice is underwritten on its own doctor roster, wellness-plan penetration, adjusted EBITDA, real-estate optionality and growth profile. The Nebraska ownership restriction under the Professional Corporation Act (Neb. Rev. Stat. 21-2216), the friendly-DVM PC plus MSO structure it requires, veterinary establishment registration with the Nebraska Board of Veterinary Medicine and Surgery, DEA registration transfer, Nebraska non-compete law, the LB 754 income-tax schedule, the 2022 FTC JAB / SAGE consent order, the May 2024 FTC / DOJ serial-acquisitions request for information, and the January 2025 FTC settlement are all subject to change; confirm current requirements with qualified Nebraska veterinary counsel before relying on them in a transaction.
If you operate a different business in Nebraska, our state-specific sub-guides walk through the named PE buyers, current valuation multiples, and Nebraska-specific deal mechanics for each vertical. You can also explore veterinary practice sales in other high-activity states.
A Nebraska veterinary practice typically sells for 5x to 7x EBITDA at the single-DVM lifestyle or rural mixed-animal tier under $500K of adjusted EBITDA (below the PE diligence floor, so it trades to other DVMs or small regional groups), 7x to 9.5x at the 2-to-3 DVM general-practice tier ($500K to $1M EBITDA), 9.5x to 11.5x at the $1M to $3M 4-to-8 DVM platform sweet spot with clean books reaching 12x, 11x to 13x at $3M-plus multi-doctor, specialty or referral scale (16x to 18x for a marquee specialty hospital), and 12x to 15x for a multi-site group. Q1 2025 transactions ranged 6x to 16x adjusted EBITDA per R.L. Hulett. The biggest mid-market lever is wellness-plan penetration above 15% of eligible general-practice cases, worth 75 to 150 basis points over the size-tier baseline. The Nebraska wrinkle is a thin bidder bench: with only Blue River PetCare confirmed in state, reaching the top of your band depends on running a process that pulls national buyers in.
Fifteen-plus PE-backed national platforms plus Mars Veterinary Health acquire across all 50 states, but only Blue River PetCare has confirmed Nebraska hospitals, in Omaha and Lincoln, so it is the one incumbent bolt-on buyer for an eastern-corridor seller. The rest would be entering Nebraska fresh: Mars Veterinary Health (VCA, Banfield, BluePearl, strategic permanent capital, not PE), NVA / Ethos (JAB Holding, 2022 FTC consent order still in force within 25 miles of a JAB clinic in California and Texas), Mission Pet Health (Shore Capital, roughly 750 clinics after the July 2025 Mission plus Southern Veterinary Partners merger), VetCor (Oak Hill plus Harvest plus Cressey), PetVet Care Centers (KKR since 2022, not Onex), Heartland (Gryphon majority recap 2024 to 2025, not American Securities), AmeriVet (AEA plus Abu Dhabi Investment Authority, not Imperial Capital), Veterinary Practice Partners (Audax), Innovetive Petcare (Metalmark), United Veterinary Care (Nordic Capital), Suveto (Levine Leichtman), Veritas (Percheron), Encore Vet Group (North Castle), Pieper (Chicago Pacific Founders), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus), VetEvolve (Varsity Healthcare) and Thrive (TSG Consumer). MedVet (95% DVM and employee owned) and Galaxy Vets (an ESOP) cover a doctor-controlled exit.
Effectively yes, but through an unusual route. The Nebraska Veterinary Medicine and Surgery Practice Act (Neb. Rev. Stat. 38-3301 et seq.) governs licensure and scope and is silent on who may own a practice. The restriction instead comes from the Nebraska Professional Corporation Act: Neb. Rev. Stat. 21-2216 requires all shareholders, directors and officers of a professional corporation, except a secretary, to be licensed in the profession the corporation renders. Because a veterinary practice organized as a professional corporation must be owned by a licensed veterinarian, a private-equity or corporate buyer cannot hold it outright. The standard answer is a friendly-DVM PC plus a management services organization: a licensed Nebraska veterinarian owns the PC that holds the license and employs the doctors, while the buyer owns a separate MSO that provides administration under a management services agreement, with stock-transfer restrictions keeping the PC friendly and management barred from controlling clinical judgment. That structure commonly adds $50K to $150K in legal cost a permissive state avoids.
Veterinary practices with monthly recurring wellness-plan revenue above 15% of eligible general-practice cases consistently trade 75 to 150 basis points above the size-tier baseline. Plan penetration across eligible US patients now exceeds 18% industry-wide, and plan members spend two to three times what non-plan clients do, converting transactional cash flow into monthly recurring revenue that PE acquirers underwrite at a higher multiple. Buyers prove penetration from the practice-management software: trailing-24-month enrolled-patient counts, retention by plan tier, per-patient annual spend uplift versus non-plan, and the contract base. A Nebraska practice that reaches market with a mature book, above 20% penetration and average tenure past 24 months, frequently clears a deal one to two turns above peers, which matters more here because the thin bidder bench gives you fewer chances to make the case.
The highest multiples in Nebraska go to practices with a 4-to-8 DVM associate bench that reduces single-doctor key-person risk, 15%-plus wellness-plan penetration, owner-DVM hours that survive the transition (32-plus hours a week, 80%-plus production), normalized associate production comp (22 to 24% straight production), low revenue concentration on any one doctor, a clean veterinary establishment registration and DEA compliance history, a current Schedule II inventory, and doctor retention built on pay and equity rather than a non-compete, since Nebraska courts void overbroad associate covenants. Specialty hospitals with board-certified specialists and emergency or around-the-clock hospitals carry 1.5x to 3x premiums over general practice and face real out-of-state demand because they are scarce in Nebraska. Multi-site groups of three or more hospitals command 12x to 15x platform-of-platform pricing.
A well-run, confidential Nebraska veterinary sale typically takes 90 to 150 days from letter of intent to close: roughly 4 to 8 weeks of preparation (wellness-plan documentation, production-comp normalization, establishment-registration and DEA review, and a friendly-DVM PC plus MSO structuring plan with board-savvy counsel), 3 to 6 weeks of confidential outreach to the national platforms plus MedVet and Galaxy Vets, 3 to 5 weeks to indications of interest and a letter of intent, then 90 to 150 days of diligence and closing. The binding operational constraints are forming the friendly PC, notifying the Nebraska Board of Veterinary Medicine and Surgery of the ownership change, and reissuing the federal DEA registration. A deal that draws FTC scrutiny can add 60 to 180 days, though that risk is usually modest in a one-platform state.
No fee to you on buy-side introductions; sell-side mandates are paid on success at closing.
Ready to talk about selling your Nebraska veterinary practice?
Book a confidential 30-minute call. We will walk through your DVM roster, wellness-plan penetration, adjusted EBITDA and production-comp normalization, real estate optionality, premise permit and DEA transfer plan, and what your practice could realistically command from the active platform pool. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing.
Book Your Free Call →EBITDA multiples for lower middle market businesses vary by size, buyer type, and vertical. The table below shows typical bands for privately-held sellers in 2026 based on GF Data and Axial 2025 benchmarks.
| EBITDA size band | Typical multiple | Dominant buyer type |
|---|---|---|
| $500K to $1M | 3.0x to 4.5x | Individual buyers, ETA, small local PE |
| $1M to $3M | 4.0x to 6.0x | Search funds, small PE, family offices |
| $3M to $10M | 5.5x to 8.0x | Lower middle market PE, strategic tuck-ins |
| $10M to $25M | 7.0x to 10.5x | Middle market PE platforms, strategic acquirers |
How buyers price a business, the terms that shrink what you keep, and a scorecard to rate yours. Read it on your own time.